Endocrinology

In older people, hypoglycaemia is an under recognised disorder and observational work suggests it is associated with significant increases in cardiovascular and cerebrovascular risks.

SGLT2 inhibitors are associated with lower rates of death for patients with type 2 diabetes

A new class of medication, known as sodium- glucose transporter-2 (SGLT2) inhibitors, is associated with lower rates of death and hospitalisation for heart failure when used to treat patients with type 2 diabetes according to a study presented at the ADA conference.

Severe obesity in high-risk youth correlates directly to increased incidence of type 2 diabetes

The risk of developing type 2 diabetes by age 20 was 12 times as high in severely obese American Indian children aged five to nine years as in normal- weight youth in that age range, according to a study presented at the ADA congress.

New LEADER trial analysis shows reduction in cardiovascular risk in people with type 2 diabetes

New findings from a post-hoc analysis of the LEADER cardiovascular (CV) outcomes trial were presented recently at the 77th annual Scientific Sessions of the American Diabetes Association (ADA).

Long-acting oral insulin tablet provides comparable glycaemic control to insulin glargine injection

A long-acting, oral insulin tablet has been found to safely improve glycaemic control as effectively as the common, injected insulin glargine in people with type 2 diabetes according to a study presented at the ADA.

DEVOTE trial: long-acting insulin results

Results of the DEVOTE trial investigating the cardiovascular (CV) safety profile of long-acting insulin, insulin degludec (Tresiba), in adults with type 2 diabetes were presented at the ADA congress.

CPD features

The role of insulin in Alzheimer's disease

There is an increasing awareness of the importance of insulin in the development of Alzheimer's disease (AD) suggesting that AD may represent a brain-specific form of diabetes and could thus be classified as type 3 diabetes.

Diabetes Knowledge: could do better, try harder

New research from Diabetes UK has found that only a small percentage of the UK public are aware of how life-changing this condition can be. Everyone needs to be aware that diabetes is a serious condition with serious consequences, which is becoming more common.

Diabetes and severe mental illness

People with a severe mental illness die 15–20 years earlier than they would have done, had they not had a severe mental illness. The principle cause of this increased mortality is from long-term conditions such as diabetes, cardiovascular disease, respiratory disease and cancer.

Diabetes prescribing in chronic kidney disease

In chronic kidney disease, diabetic patients need diligent consideration of glycaemic targets; the risks versus benefits of glucose lowering treatment need to be assessed carefully.

Diabetes and cardiovascular disease

Patients with type 2 diabetes are at greater risk for heart disease and stroke even when glucose levels are under control. In this one-to-one interview, Professor Stephen Bain, Professor of Medicine (Diabetes) at ABM University Health Board, discusses new advances in cardiovascular and diabetes management.

Diabetes: newer agents for the older patient?

This article is based on a presentation given by Dr Chris Smith, Consultant in Diabetes and Endocrinology, RAH and Diabetes UK Clinical Champion, at the GM Conference Ageing and Healthcare Today, held in Edinburgh.

More endocrinology features...

Sign In

Confirm

Endocrinology

Call for papers: Endocrinology